129 related articles for article (PubMed ID: 31655804)
1. Increase in Carbohydrate Antigen 19-9 Levels without Tumor Progression after Polaprezinc Administration that Induced Deep Vein Thrombosis in a Colon Cancer Patient.
Naito M; Torii R; Hashimoto Y; Kawamoto Y; Hayashi K; Shinoda H; Honjo Y; Hiroyoshi M
Chemotherapy; 2019; 64(3):163-166. PubMed ID: 31655804
[TBL] [Abstract][Full Text] [Related]
2. Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy.
Fujii H; Hirose C; Ishihara M; Iihara H; Imai H; Tanaka Y; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K; Suzuki A
Anticancer Res; 2018 Nov; 38(11):6367-6373. PubMed ID: 30396959
[TBL] [Abstract][Full Text] [Related]
3. Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study.
Sakae K; Suka M; Yanagisawa H
J Clin Psychopharmacol; 2020; 40(6):599-606. PubMed ID: 33044355
[TBL] [Abstract][Full Text] [Related]
4. [A case of polaprezinc-induced pneumonitis].
Eto S; Yoshinaga T; Ushijima S; Saishoji T
Nihon Kokyuki Gakkai Zasshi; 2003 Aug; 41(8):561-4. PubMed ID: 14503344
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data.
Furihata K; Tsuchikawa M; Miwa T; Naito Y; Oba K; Sakagami M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316581
[TBL] [Abstract][Full Text] [Related]
6. [The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy].
Mizukami Y; Sato J; Nihei S; Kashiwaba M; Kudo K; Okuyama H; Tamura K
Gan To Kagaku Ryoho; 2016 Aug; 43(8):979-83. PubMed ID: 27539040
[TBL] [Abstract][Full Text] [Related]
7. Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer.
Watanabe T; Ishihara M; Matsuura K; Mizuta K; Itoh Y
Int J Cancer; 2010 Oct; 127(8):1984-90. PubMed ID: 20104529
[TBL] [Abstract][Full Text] [Related]
8. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
[TBL] [Abstract][Full Text] [Related]
9. Oral treatment of pressure ulcers with polaprezinc (zinc L-carnosine complex): 8-week open-label trial.
Sakae K; Yanagisawa H
Biol Trace Elem Res; 2014 Jun; 158(3):280-8. PubMed ID: 24691900
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of zinc-carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitis.
Itagaki M; Saruta M; Saijo H; Mitobe J; Arihiro S; Matsuoka M; Kato T; Ikegami M; Tajiri H
Scand J Gastroenterol; 2014 Feb; 49(2):164-72. PubMed ID: 24286534
[TBL] [Abstract][Full Text] [Related]
11. Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats.
Kono T; Asama T; Chisato N; Ebisawa Y; Okayama T; Imai K; Karasaki H; Furukawa H; Yoneda M
Life Sci; 2012 Jan; 90(3-4):122-30. PubMed ID: 22100444
[TBL] [Abstract][Full Text] [Related]
12. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites.
Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T
Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862
[TBL] [Abstract][Full Text] [Related]
13. Polaprezinc, a gastroprotective agent: attenuation of monochloramine-evoked gastric DNA fragmentation.
Suzuki H; Mori M; Seto K; Nagahashi S; Kawaguchi C; Morita H; Suzuki M; Miura S; Yoneta T; Ishii H
J Gastroenterol; 1999; 34 Suppl 11():43-6. PubMed ID: 10616765
[TBL] [Abstract][Full Text] [Related]
14. Effects of polaprezinc on morphological change of the tongue in zinc-deficient rats.
Kinomoto T; Sawada M; Ohnishi Y; Yamaguchi T; Tsuge S; Ogawa S; Washizuka M; Minaguchi J; Mera Y; Takehana K
J Oral Pathol Med; 2010 Sep; 39(8):617-23. PubMed ID: 21054547
[TBL] [Abstract][Full Text] [Related]
15. [The effects of Rebamipide and Polaprezinc mouthwash and uptake on mucositis induced by chemotherapy].
Fukuhara K; Terakura M; Katsuragi K; Kodama S; Morisya Y; Hayaishi Y; Nakanishi C
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2603-6. PubMed ID: 22189226
[TBL] [Abstract][Full Text] [Related]
16. Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity.
Tsutsumi K; Kaname T; Shiraishi H; Kawashiri T; Egashira N
J Pharmacol Sci; 2016 Jun; 131(2):146-9. PubMed ID: 27262900
[TBL] [Abstract][Full Text] [Related]
17. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc.
Nishiwaki H; Kato S; Sugamoto S; Umeda M; Morita H; Yoneta T; Takeuchi K
J Physiol Pharmacol; 1999 Jun; 50(2):183-95. PubMed ID: 10424716
[TBL] [Abstract][Full Text] [Related]
18. [Orally administered polaprezinc significantly improves taste disorders in ovarian cancer patient undergoing chemotherapy].
Nishijima S; Yanase T; Hata Y; Tamura R; Tsuneki I; Tamura M; Kurabayashi T
Gan To Kagaku Ryoho; 2011 Apr; 38(4):689-92. PubMed ID: 21499007
[TBL] [Abstract][Full Text] [Related]
19. Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients.
Fukushima T; Horike H; Fujiki S; Kitada S; Sasaki T; Kashihara N
Ther Apher Dial; 2009 Jun; 13(3):213-9. PubMed ID: 19527468
[TBL] [Abstract][Full Text] [Related]
20. A Case of Copper Deficiency-Induced Pancytopenia With Maintenance Hemodialysis Outpatient Treated With Polaprezinc.
Kadoya H; Uchida A; Kashihara N
Ther Apher Dial; 2016 Aug; 20(4):422-3. PubMed ID: 26948531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
